Location History:
- Asaka, JP (2009)
- Kanagawa, JP (2018 - 2019)
- Ashigarakami-gun, JP (2024)
Company Filing History:
Years Active: 2009-2024
Title: Rie Hando: Innovator in Medical Treatments
Introduction
Rie Hando is a prominent inventor based in Kanagawa, Japan. She has made significant contributions to the field of medical treatments, particularly in the area of lysosomal storage diseases and pluripotent stem cell culture methods. With a total of 4 patents to her name, Hando's work is paving the way for advancements in medical science.
Latest Patents
One of Hando's latest patents is a treatment agent for lysosomal storage disease. The objective of this invention is to provide an effective treatment agent that includes a cell structure composed of multiple biocompatible polymer blocks and various types of cells. This innovative approach aims to enhance the treatment options available for patients suffering from these diseases.
Another significant patent is her culture method for pluripotent stem cells. This method involves culturing pluripotent stem cells on a specific cell culture surface using a medium with a low concentration of 2-mercaptoethanol. The presence of a specialized polypeptide plays a crucial role in this process, ensuring the effective growth and maintenance of pluripotent stem cells.
Career Highlights
Throughout her career, Rie Hando has worked with notable organizations such as Fujifilm Corporation and Kyoto Prefectural Public University Corporation. Her experience in these institutions has allowed her to develop and refine her innovative ideas, contributing to her success as an inventor.
Collaborations
Hando has collaborated with talented individuals in her field, including Keita Hagiya and Yuta Murakami. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking inventions.
Conclusion
Rie Hando's contributions to medical science through her patents and collaborations highlight her role as an influential inventor. Her work continues to inspire advancements in treatments for lysosomal storage diseases and stem cell research.